| Trial ID: | L3661 |
| Source ID: | NCT06703268
|
| Associated Drug: |
Hsk7653 10 Mg
|
| Title: |
A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: HSK7653 10 mg|DRUG: Daily DPP-4 inhibitor
|
| Outcome Measures: |
Primary: Time in range, The change in time in range (TIR) of continuous glucose monitoring (CGM) relative to the baseline after 24 weeks of treatment., 24 weeks | Secondary: HbA1c, Change from baseline in HbA1c after 24 weeks, 24 weeks|Fasting glucose, Change from baseline in fasting glucose after 24 weeks, 24 weeks|Mean glucose, Change from baseline in mean glucose after 24 weeks, 24 weeks|Treatment-emergent adverse events., The incidence of treatment-emergent adverse events., 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
64
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2024-01-15
|
| Completion Date: |
2024-11-20
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-25
|
| Locations: |
Chu Hsien-I Memorial Hospital, Tianjin Medical University, Tianjin, China
|
| URL: |
https://clinicaltrials.gov/show/NCT06703268
|
